Source:http://linkedlifedata.com/resource/pubmed/id/10946156
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
2000-9-20
|
pubmed:abstractText |
It is a well-known fact that a large percentage of alcoholics smoke, and in the experimental rat, intermittent nicotine administration enhances ethanol intake and ethanol preference in a free-choice situation between 6% (v/v) ethanol and water. The present study focuses on the possible involvement of central and/or peripheral nicotine acetylcholine receptors (nAChR) in nicotine-induced sensitization to dopamine-related behavioral effects of ethanol. Wistar rats drinking less than 60% of their total daily fluid from a 6% ethanol solution were used in the study. Nicotine, vehicle, mecamylamine, hexamethonium, mecamylamine+nicotine, and hexamethonium+nicotine were administered subchronically for 15 days. All groups, except the vehicle pre-treated group, markedly increased their ethanol preference to approximately 80%, as well as their ethanol intake. NMRI mice received the same treatments for 10 days, after which ethanol (2.5 g/kg, intraperitoneal (i.p.)) was given acutely and locomotor activity was recorded. Ethanol-induced locomotor stimulation was enhanced in most groups, as compared to the vehicle pre-treated group. Administration of quarternary autonomic drugs to ethanol high-preferring rats (hexamethonium, methscopolamine, sotalol and phentolamine) according to different acute and chronic treatment protocols indicated that the enhanced ethanol intake may involve increased ganglionic and/or peripheral muscarinic neurotransmission. Taken together, the above results indicate that peripheral mechanisms may be involved in the enhancement of dopamine-related behavioral effects of ethanol observed after subchronic intermittent treatment with nicotinic drugs.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0741-8329
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
21
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
37-47
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:10946156-Alcohol Drinking,
pubmed-meshheading:10946156-Animals,
pubmed-meshheading:10946156-Drinking,
pubmed-meshheading:10946156-Male,
pubmed-meshheading:10946156-Mice,
pubmed-meshheading:10946156-Motor Activity,
pubmed-meshheading:10946156-Nicotine,
pubmed-meshheading:10946156-Nicotinic Agonists,
pubmed-meshheading:10946156-Nicotinic Antagonists,
pubmed-meshheading:10946156-Rats,
pubmed-meshheading:10946156-Rats, Wistar,
pubmed-meshheading:10946156-Receptors, Nicotinic
|
pubmed:year |
2000
|
pubmed:articleTitle |
Peripheral involvement in nicotine-induced enhancement of ethanol intake.
|
pubmed:affiliation |
Department of Pharmacology, Institute of Physiology and Pharmacology, Göteborg University, Sweden.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|